Mark Dayan

Mark Dayan is a policy analyst at the Nuffield Trust, where he leads the Brexit programme. He has been vocal about the significant impact of Brexit on the UK's medicine supply chain, highlighting that recent shortages of vital medications, such as those for epilepsy and cystic fibrosis, are a growing concern for patient health.